ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Chojiro Yamashita
Masayoshi Okada
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okada, K.
Right arrow Articles by Okada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okada, K.
Right arrow Articles by Okada, M.

Ann Thorac Surg 1995;60:1723-1728
© 1995 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Successful 24-Hour Rabbit Heart Preservation by Hypothermic Continuous Coronary Microperfusion With Oxygenated University of Wisconsin Solution

Kenji Okada, MD, Chojiro Yamashita, MD, Masayoshi Okada, MD, Morihito Okada, MD

Division II, Department of Surgery, Kobe University School of Medicine, Kobe, Japan

Accepted for publication July 28, 1995.

Background. This study assessed whether a combination of hypothermic continuous coronary microperfusion and oxygenated University of Wisconsin Solution (UWS) improves postischemic functional recovery and minimizes myocardial tissue edema.

Methods. Isolated rabbit hearts were divided into four groups (n = 6 each): group I (immediate reperfusion), group II (simple cold storage in UWS), group III (hypothermic continuous coronary microperfusion with UWS), and group IV (hypothermic continuous coronary microperfusion with oxygenated UWS). Hearts in groups II, III, and IV were preserved for 24 hours. Preischemic and postischemic cardiac function was measured using a Langendorff apparatus.

Results. Hearts in group I showed complete functional recovery, whereas cardiac output in group II was inadequate. In groups III and IV, the percentage recovery rate (post/pre) of cardiac output was 57.0% ± 3.1% and 82.2% ± 9.1%, respectively (p < 0.05). In groups III and IV, perfusion pressures at the end of 24-hour preservation increased from the initial 5 mm Hg to 12.3 ± 2.7 and 8.3 ± 1.4 mm Hg (p < 0.05), respectively. In groups I, III, and IV, the percentage tissue water content was 82.8 ± 1.0, 86.7 ± 1.7, and 83.8 ± 1.6, respectively (p < 0.05 for group III versus groups I and IV). There was a significant correlation between the percentage tissue water content and coronary perfusion pressure at the end of the 24-hour preservation (r = 0.60, p = 0.040) and a significant inverse correlation between percentage tissue water content and percentage recovery rate of cardiac output (r = -0.69, p = 0.014). In ultrastructural examination, myocardial tissue edema was limited and mitochondria were well preserved in group IV.

Conclusion. We conclude that the combination of a hypothermic continuous coronary microperfusion technique and oxygenation of UWS was the procedure of choice for reducing tissue edema and improving both the coronary microcirculation and functional recovery during 24-hour heart preservation.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Abunasra, R. T. Smolenski, J. Yap, J. Jayakumar, M. Sheppard, and M. H. Yacoub
Comparison of two gene transfer models for the attenuation of myocardial ischemia-reperfusion injury following preservation for cardiac transplantation.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 772 - 778.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. P. Fitton, C. J. Barreiro, P. N. Bonde, C. Wei, F. Gage, R. Rodriguez, and J. V. Conte
Attenuation of DNA Damage in Canine Hearts Preserved by Continuous Hypothermic Perfusion
Ann. Thorac. Surg., November 1, 2005; 80(5): 1812 - 1820.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. J. Abunasra, R. T. Smolenski, J. Yap, M. Sheppard, T. O'Brien, and M. H. Yacoub
Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation
J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 998 - 1006.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Pellegrini, A. Jeppsson, C. B. Taner, T. O’Brien, V. M. Miller, H. D. Tazelaar, and C. G. A. McGregor
HIGHLY EFFICIENT EX VIVO GENE TRANSFER TO THE TRANSPLANTED HEART BY MEANS OF HYPOTHERMIC PERFUSION WITH A LOW DOSE OF ADENOVIRAL VECTOR
J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 493 - 500.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. K. Nickless, M. Rabinov, S. M. Richards, R. A.J. Conyers, and F. L. Rosenfeldt
Continuous Perfusion Improves Preservation of Donor Rat Hearts: Importance of the Implantation Phase
Ann. Thorac. Surg., May 1, 1998; 65(5): 1265 - 1272.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1995 by The Society of Thoracic Surgeons.